Buy Orencia Abatacept

Orencia (abatacept) is a prescription medication used to treat autoimmune conditions like rheumatoid arthritis and psoriatic arthritis. This 250mg vial formulation supports immune system modulation for adults and children. Store at ambient temperature for convenience and stability.

Strength

250mg x 15ml

Pack Size

Storage

Ambient

Manufacturer / TM Owner

Bristol- Myers Squibb

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Uses / Indications

Abatacept is commonly prescribed to reduce inflammation and joint damage in rheumatoid arthritis when other treatments have not been effective. It is also used for psoriatic arthritis and juvenile idiopathic arthritis in appropriate patients. This medication works by targeting specific immune cells to help control overactive responses that cause joint pain and swelling.

Side Effects

Patients using abatacept often experience reduced joint tenderness and improved mobility over time. Some may notice a gradual decrease in morning stiffness and swelling in affected joints. Individual responses vary, and benefits typically become more apparent with consistent use.

Precautions & Warnings

Keep Orencia vials at room temperature and protect from extreme heat or cold. Always check the solution for particles or discoloration before use. Do not freeze or shake the vial vigorously. Dispose of used needles and vials properly according to local regulations.

Avoid Interactions

Abatacept may interact with other medications that affect the immune system, such as immunosuppressants or biologics. Combining it with live vaccines is generally not recommended due to potential reduced vaccine effectiveness. Always inform your healthcare provider about all medications and supplements you are taking.

References

Frequently Asked Questions

Orencia is used for rheumatoid arthritis, psoriatic arthritis, and juvenile idiopathic arthritis in patients who have not responded well to other treatments.

Orencia is given as an intravenous infusion by a healthcare professional, typically every few weeks.

Yes, Orencia vials should be stored at room temperature away from light and moisture.

Some patients may experience headache, nausea, or injection site reactions, though not everyone will experience side effects.

Orencia is approved for use in children with juvenile idiopathic arthritis under medical supervision.

Published by GNH India Pharmaceuticals Limited

Last updated: 18 May 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.